NEXT Oncology

Futó vizsgálatok

• Még nem toboroz

  A Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha (FRα)-Expressing Solid Tumors

  NCT07909356· 1. fázis· Forrás

• Toboroz

  A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT07719361· 1. fázis· Forrás

• Toboroz

  A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  NCT07705334· 1. fázis· Forrás

• Toboroz

  A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  NCT07458347· 1. fázis· Forrás

• Toboroz

  Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

  NCT07397338· 1/2. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  NCT07321106· 1. fázis· Forrás

• Toboroz

  A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

  NCT07244341· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

  NCT07223047· 1/2. fázis· Forrás

• Toboroz

  M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

  NCT07166601· 1. fázis· Forrás

• Toboroz

  PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

  NCT07190469· 1. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  NCT07090499· 1. fázis· Forrás

• Toboroz

  A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

  NCT06997029· 1. fázis· Forrás

• Toboroz

  AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

  NCT07094113· 1. fázis· Forrás

• Toboroz

  STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  NCT06975293· 1/2. fázis· Forrás

• Toboroz

  A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

  NCT06907043· 1/2. fázis· Forrás

• Toboroz

  BBO-11818 in Adult Subjects With KRAS Mutant Cancer

  NCT06917079· 1. fázis· Forrás

• Toboroz

  First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  NCT06799065· 1/2. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

  NCT06720987· 1. fázis· Forrás

• Toboroz

  A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

  NCT06413680· 1/2. fázis· Forrás

• Fut, nem toboroz

  Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

  NCT06577987· 1. fázis· Forrás

• Toboroz

  Study of STP938 (Dencatistat) in Advanced Solid Tumours

  NCT06297525· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  NCT06440005· 1. fázis· Forrás

• Toboroz

  Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  NCT06239194· 1/2. fázis· Forrás

• Toboroz

  This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

  NCT06451497· 1. fázis· Forrás

• Toboroz

  A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

  NCT06385925· 1/2. fázis· Forrás

• Toboroz

  BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

  NCT06120283· 1. fázis· Forrás

• Toboroz

  A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

  NCT06090266· 1/2. fázis· Forrás

• Toboroz

  A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  NCT06067841· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

  NCT05787587· 1. fázis· Forrás

• Toboroz

  Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

  NCT05784688· 1/2. fázis· Forrás

• Fut, nem toboroz

  A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

  NCT05731271· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

  NCT05585320· 1/2. fázis· Forrás

• Fut, nem toboroz

  Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

  NCT05462717· 1. fázis· Forrás

• Fut, nem toboroz

  Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

  NCT05464030· 1. fázis· Forrás

• Toboroz

  Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  NCT05379985· 1/2. fázis· Forrás

• Fut, nem toboroz

  P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

  NCT05239143· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of NDI 1150-101 in Patients With Solid Tumors

  NCT05128487· 1/2. fázis· Forrás

• Fut, nem toboroz

  Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

  NCT04794699· 1. fázis· Forrás

• Toboroz

  Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

  NCT04665206· 1/2. fázis· Forrás

• Toboroz

  Study of PF-07248144 in Advanced or Metastatic Solid Tumors

  NCT04606446· 2. fázis· Forrás

• Fut, nem toboroz

  Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

  NCT04526691· 1. fázis· Forrás

• Fut, nem toboroz

  TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

  NCT04485013· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

  NCT03611868· 1/2. fázis· Forrás

• Toboroz

  A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  NCT03460977· 1. fázis· Forrás

• Fut, nem toboroz

  First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

  NCT03401385· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák17 toboroz
• Hasnyálmirigyrák14 toboroz
• Vastagbélrák13 toboroz
• Prosztatarák9 toboroz
• Petefészekrák5 toboroz
• Szarkóma5 toboroz
• Máj- és epeúti rák4 toboroz
• Tripla negatív emlőrák4 toboroz
• Fej-nyaki daganatok3 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• Hólyagrák3 toboroz
• Méhtestrák3 toboroz
• Melanóma3 toboroz
• Mezotelióma3 toboroz
• Vesedaganat3 toboroz
• Áttétes emlőrák2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Follikuláris limfóma1 toboroz
• Méhnyakrák1 toboroz
• Pajzsmirigyrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

  NCT07408089· 1. fázis· Forrás

• Toboroz

  A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  NCT06774963· 1. fázis· Forrás

• Leállították

  First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers

  NCT06625515· 1. fázis· Forrás

• Leállították

  Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

  NCT06287463· 1. fázis· Forrás

• Leállították

  A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

  NCT06448364· 1. fázis· Forrás

• Leállították

  A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors

  NCT06257758· 1/2. fázis· Forrás

• Leállították

  Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

  NCT06052852· 1. fázis· Forrás

• Leállították

  A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

  NCT05917470· 1/2. fázis· Forrás

• Leállították

  Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

  NCT05827614· 1. fázis· Forrás

• Lezárult

  A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

  NCT05753722· 1. fázis· Forrás

• Leállították

  Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

  NCT05631574· 1. fázis· Forrás

• Lezárult

  Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

  NCT05479812· 1. fázis· Forrás

• Lezárult

  Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

  NCT05259696· 1/2. fázis· Forrás

• Leállították

  Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

  NCT05228015· 1. fázis· Forrás

• Lezárult

  Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

  NCT04902872· 1/2. fázis· Forrás

• Lezárult

  Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

  NCT04672434· 1. fázis· Forrás

• Toboroz

  Evaluate the Safety and Clinical Activity of HH2853

  NCT04390737· 1/2. fázis· Forrás

• Lezárult

  TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

  NCT04306900· 1. fázis· Forrás

• Toboroz

  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  NCT04198766· 1/2. fázis· Forrás

• Leállították

  Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

  NCT04171141· 1. fázis· Forrás

• Leállították

  Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

  NCT04152018· 1. fázis· Forrás

• Lezárult

  Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

  NCT04121676· 1. fázis· Forrás

• Lezárult

  A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

  NCT03821233· 1. fázis· Forrás

• Toboroz

  Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  NCT03715933· 1. fázis· Forrás

• Lezárult

  PRS-343 in HER2-Positive Solid Tumors

  NCT03330561· 1. fázis· Forrás

• Lezárult

  Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

  NCT02635672· 1. fázis· Forrás